Selected article for: "human immunoglobulin and intravenous corticosteroid"

Author: Ru Liu; Xiaoyan Ming; Ou Xu; Jianli Zhou; Hui Peng; Ning Xiang; Jiaming Zhang; Hong Zhu
Title: Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data
  • Document date: 2020_3_3
  • ID: 9lissxsy_8
    Snippet: Epidemiological and clinical characteristics, laboratory and radiological findings, treatment and outcomes data were first-hand obtained. The data were reviewed by a trained team of physicians. Information recorded included demographic data, medical history, exposure history, comorbidities, symptoms and signs, laboratory findings, chest computed tomographic (CT) scans, nucleic acid detection of throat swab, treatment measures and in-hospital adve.....
    Document: Epidemiological and clinical characteristics, laboratory and radiological findings, treatment and outcomes data were first-hand obtained. The data were reviewed by a trained team of physicians. Information recorded included demographic data, medical history, exposure history, comorbidities, symptoms and signs, laboratory findings, chest computed tomographic (CT) scans, nucleic acid detection of throat swab, treatment measures and in-hospital adverse events. The date of disease onset was defined as the day when the symptom was noticed. Treatment included antiviral therapy, antibiotics or anti-fungus drugs, corticosteroid therapy, intravenous human albumin or immunoglobulin, thymosin, traditional Chinese medicine, mesenchymal stem cell therapy and respiratory support. None received kidney replacement therapy, plasma exchange or artificial liver.

    Search related documents:
    Co phrase search for related documents
    • adverse event and chinese medicine: 1, 2, 3
    • adverse event and corticosteroid therapy: 1
    • adverse event and CT scan: 1, 2, 3, 4, 5, 6, 7
    • adverse event and disease onset: 1, 2
    • adverse event and exposure history: 1
    • adverse event and hospital adverse event: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adverse event and human albumin: 1
    • adverse event and kidney replacement therapy: 1
    • adverse event and medical history: 1, 2, 3, 4
    • adverse event and outcome treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • adverse event and plasma exchange: 1, 2
    • adverse event and replacement therapy: 1, 2
    • adverse event and respiratory support: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adverse event and stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • adverse event and stem cell therapy: 1, 2
    • adverse event and traditional chinese medicine: 1
    • antiviral therapy and artificial liver: 1
    • antiviral therapy and chinese medicine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
    • antiviral therapy and corticosteroid therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21